Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Notice of updates
We’ve updated our Financial Services Guide (FSG), effective 18 November 2025. By continuing to use our services after this date, you accept the revised terms.
Read FSG
Mean Reversion
Neutral
Trend
Neutral
Event
Neutral
Mqv
Very Weak
Garp
Very Weak
Mqv Small
Neutral
Value
Consensus
Price
Very Strong
Earnings
Very Weak
Earnings
Very Weak
Dividends
Very Weak
Capital Efficiency
Very Weak
Balance Sheet
Very Weak
Website
Invex Therapeutics Ltd.
Telephone
Address
Market Cap
PE
EV/EBITDA
DIV Yield
Franking
Ex Dividend Date (est.)
52 weeks range
Low 0.06 - 0.18
Trade Value (12mth)
AU$706.00
1 week
12.5%
1 month
-3.57%
YTD
92.86%
1 year
68.75%
All time high
0.52
EPS 3 yr Growth
-87.80%
EBITDA Margin
0.00%
Operating Cashflow
-$1m
Free Cash Flow Return
-11.90%
ROIC
-8.70%
Interest Coverage
0.00
Quick Ratio
24.80
Shares Outstanding (Fully Diluted)
75m
HALO Sector
Healthcare
Next Company Report Date
13-Aug-26
Next Ex Dividend Date
N/A
Next Dividend Pay Date
N/A
Reporting Currency
AUD
Short Sell (% of issue)
0.56
| Date | Announcements |
| 10 November 25 | |
| 10 November 25 | |
| 10 November 25 | |
| 07 November 25 | |
| 07 November 25 |
Historical data
Forecast data
| AUD | 2021 | 2022 | 2023 | 2024 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | |||
| Per Share, Growth & Valuations | |||||||||||||
EPS (Basic) | $ |  | | | | -0.1 | -0.02 | -0.01 | | | | ||
EPS (Fully Diluted) | $ | | | | | -0.1 | -0.02 | -0.01 | | | | ||
Growth | % | | | | | -96 | 78.9 | 70.6 | | | | ||
PE | X | | | | | N/A | N/A | N/A | | | | ||
EV/EBITDA | X | | | | | N/A | N/A | N/A | | | | ||
Ex Dividend Date (est.)
DIV Yield
Franking Level
DPSg
Quality Yield
Falling Divs over next 2
Consensus Score
Recommendation
EPS 1 month Change
Quality Yield
Falling Divs over next 2
Percent of Issue
Value ($M)
Prior Change
7 Day Change
1 Month Change
3 Months Change
Access data on short interest, stock performance, and potential short-selling candidates across various markets to make informed decisions and optimize your trading strategies.
